Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 1,482,000 | 1,460,000 | 1,082,000 | 939,000 | 876,000 |
| Cost of Goods | 309,000 | 363,000 | 292,000 | 257,000 | 243,000 |
| Gross Profit | 1,173,000 | 1,097,000 | 790,000 | 682,000 | 633,000 |
| Operating Expenses | 815,000 | 649,000 | 526,000 | 486,000 | 460,000 |
| Operating Income | 358,000 | 448,000 | 264,000 | 196,000 | 173,000 |
| Interest Expense | 19,000 | 14,000 | 11,000 | 11,000 | 12,000 |
| Other Income | 9,000 | -2,000 | 2,000 | -1,000 | -3,000 |
| Pre-tax Income | 348,000 | 432,000 | 255,000 | 184,000 | 158,000 |
| Income Tax | 90,000 | 119,000 | 61,000 | 47,000 | 34,000 |
| Net Income Continuous | 258,000 | 313,000 | 194,000 | 137,000 | 124,000 |
| Net Income | $258,000 | $313,000 | $194,000 | $137,000 | $124,000 |
| EPS Basic Total Ops | 0.31 | 0.37 | 0.23 | 0.16 | 0.15 |
| EPS Basic Continuous Ops | 0.31 | 0.37 | 0.23 | 0.17 | 0.15 |
| EPS Diluted Total Ops | 0.30 | 0.36 | 0.23 | 0.17 | 0.15 |
| EPS Diluted Continuous Ops | 0.30 | 0.36 | 0.23 | 0.16 | 0.15 |
| EBITDA(a) | $358,000 | $448,000 | $264,000 | $196,000 | $173,000 |